Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and have disclosed the following: M.H. has received consulting fees from Pantec and Procter & Gamble and grants from Almirall, Leo Pharma, and Galderma.
Fractional laser-assisted delivery of methyl aminolevulinate: Impact of laser channel depth and incubation time†
Version of Record online: 4 DEC 2012
Copyright © 2012 Wiley Periodicals, Inc.
Lasers in Surgery and Medicine
Volume 44, Issue 10, pages 787–795, December 2012
How to Cite
Haak, C. S., Farinelli, W. A., Tam, J., Doukas, A. G., Anderson, R. R. and Hædersdal, M. (2012), Fractional laser-assisted delivery of methyl aminolevulinate: Impact of laser channel depth and incubation time. Lasers Surg. Med., 44: 787–795. doi: 10.1002/lsm.22102
- Issue online: 21 DEC 2012
- Version of Record online: 4 DEC 2012
- Manuscript Accepted: 9 NOV 2012
- Familien Hede Nielsen Foundation
- The Group Medica Foundation
- The Aage Bang Foundation
- The A. P. Møller Foundation
Vol. 45, Issue 9, 617, Version of Record online: 18 OCT 2013
- 1The incidence of nonmelanoma skin cancers and actinic keratoses in South Florida. J Clin Aesthet Dermatol 2012; 5(4): 20–24., .
- 2WHO. Skin cancers. 2012. http://www.who.int/uv/faq/skincancer/en/index1.html
- 3British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. Guidelines for topical photodynamic therapy: Update. Br J Dermatol 2008; 159(6): 1245–1266., , .
- 11Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: Continuous versus fractional ablation. Exp Dermatol 2010; 19(9): 806–812., , , .
- 18Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149(6): 1242–1249., , , , , , , , , , , , , .
- 24The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp. J Dermatolog Treat 2009; 21(4): 252–257., , .